VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 60 filers reported holding VIRACTA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,583,093 | -26.4% | 1,522,204 | -0.2% | 0.00% | – |
| Q2 2023 | $2,150,028 | -13.3% | 1,524,843 | -2.2% | 0.00% | -100.0% |
| Q1 2023 | $2,480,119 | +7.5% | 1,559,823 | -1.3% | 0.00% | 0.0% |
| Q4 2022 | $2,306,535 | -67.3% | 1,579,819 | -4.5% | 0.00% | -50.0% |
| Q3 2022 | $7,064,000 | +8.9% | 1,654,155 | -1.1% | 0.00% | 0.0% |
| Q2 2022 | $6,488,000 | -19.8% | 1,672,162 | -1.6% | 0.00% | 0.0% |
| Q1 2022 | $8,087,000 | +40.7% | 1,698,854 | +7.9% | 0.00% | +100.0% |
| Q4 2021 | $5,748,000 | -54.5% | 1,574,601 | -0.1% | 0.00% | -66.7% |
| Q3 2021 | $12,646,000 | -29.2% | 1,576,846 | +0.1% | 0.00% | -25.0% |
| Q2 2021 | $17,862,000 | +23.2% | 1,575,174 | +0.5% | 0.00% | +33.3% |
| Q1 2021 | $14,496,000 | – | 1,567,082 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 689,709 | $717,297 | 0.22% |
| Aisling Capital Management LP | 288,571 | $300,114 | 0.12% |
| BVF INC/IL | 3,614,662 | $3,759,248 | 0.10% |
| TRUST CO OF TOLEDO NA /OH/ | 33,213 | $34,542 | 0.01% |
| MAI Capital Management | 397,670 | $413,577 | 0.01% |
| Laurion Capital Management LP | 698,000 | $725,920 | 0.00% |
| RP Management, LLC | 3,700 | $3,848 | 0.00% |
| UNITED BANK | 20,000 | $20,800 | 0.00% |
| BOURGEON CAPITAL MANAGEMENT LLC | 7,500 | $7,800 | 0.00% |
| XTX Topco Ltd | 12,084 | $12,567 | 0.00% |